Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)

ClinicalTrials.gov ID: NCT01730170

Public ClinicalTrials.gov record NCT01730170. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs

Study identification

NCT ID: NCT01730170
Recruitment status: Completed
Study type: Observational
Phase: Not listed
Lead sponsor: Stanford University; Other
Enrollment: 565 participants

Conditions and interventions

Conditions

Interventions

Not listed

Eligibility (public fields only)

Age range: 14 Years to 45 Years
Sex: Female
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 31, 2012
Primary completion: Dec 11, 2022
Completion: Dec 11, 2022
Last update posted: Jul 12, 2023

2013 – 2022

United States locations

U.S. sites: 20
U.S. states: 15
U.S. cities: 19

Facility	City	State	ZIP	Site status
University of Alabama Birmingham Hospital- UAB	Birmingham	Alabama	35294-0021	—
University of Arizona - University Medical Center	Tucson	Arizona	85724-5023	—
Keck Hospital of the University of Southern California	Los Angeles	California	90089	—
Stanford University	Stanford	California	94305	—
University of Miami Hospital - University of Miami School of Medicine	Miami	Florida	33136	—
Emory University School of Medicine	Atlanta	Georgia	30322	—
Medical College of Georgia at Georgia Regents University	Augusta	Georgia	30912-0004	—
Northwestern Memorial Hospital-Northwestern University Feinberg School of Medicine	Chicago	Illinois	60611	—
John Hopkins Bayview Medical Center	Baltimore	Maryland	21224-2735	—
Brigham & Women's Hospital - Harvard	Boston	Massachusetts	02115-6110	—
Henry Ford Hospital	Detroit	Michigan	48202-2608	—
Minnesota Epilepsy Group	Roseville	Minnesota	55113	—
North Shore Jewish Medical Center	Manhasset	New York	11040-1402	—
New York University School of Medicine	New York	New York	10016-6402	—
Columbia University Medical Center/NY Presbyterian Hospital	New York	New York	10032-7133	—
Wake Forest Baptist Health-Wake Forest University School of Medicine	Winston-Salem	North Carolina	27157	—
University of Cincinnati UC Health University Hospital	Cincinnati	Ohio	45267-0525	—
Geisinger Medical Center	Danville	Pennsylvania	17822-9800	—
University of Pittsburgh Medical Center	Pittsburgh	Pennsylvania	15213	—
University of Washington Medical Center	Seattle	Washington	98104	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01730170, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jul 12, 2023 · Synced Jul 22, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01730170 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →